AnthonySerritellaMD

Hospital Medicine/Hospitalist

Physician

Dr. Serritella is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

17 citations
Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate Cancer.
Anthony V Serritella, Daniel Shevrin, Elisabeth I Heath, James L Wade, Elia Martinez
Clinical Cancer Research. 2022-04-14
12 citations
Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings.
Po-Hung Hsieh, Alec J Kacew, Marie Dreyer, Anthony V Serritella, Randall W Knoebel
NPJ Breast Cancer. 2022-03-14
2 citations
Safety and efficacy of catheter-directed therapy versus anticoagulation alone in a higher-risk acute pulmonary embolism population
Andrew Putnam, Kyle A Carey, Alexandru Marginean, Anthony Serritella, Janet Friant
Journal of Thrombosis and Thrombolysis. 2021-05-25

Abstracts/Posters

[Board 481] Analyzing the Impact of Catheter Directed Therapy on Long Term Clinical Outcomes in Patients With Acute Pulmonary Embolism
Anthony Serritella, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/16/2019

No Clinically Meaningful Difference in Survival Between Nivolumab plus Ipilimumab and Nivolumab Alone in Advanced Cancers Other Than MelanomaSeptember 21st, 2023
Combination Immunotherapy Shows No Additional Benefit for Most Advanced CancersSeptember 22nd, 2023